HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.
The post Vaccines causing minimal headwinds in COVID-19 testing volumes appeared first on Healthcare Business International.